Skip to main content

Christian Spies, MD, FACC, FSCAI

04/30/2014
As hospitals’ transcatheter aortic valve replacement (TAVR) programs evolve, patient length of stay (LOS) and enhanced clinical outcomes have been recognized as opportunities for program optimization.
As hospitals’ transcatheter aortic valve replacement (TAVR) programs evolve, patient length of stay (LOS) and enhanced clinical outcomes have been recognized as opportunities for program optimization.
As hospitals’ transcatheter...
04/30/2014
Cath Lab Digest
Original Contribution
09/15/2008
ABSTRACT: Background. Transcatheter patent foramen ovale (PFO) closure can be performed with various devices. However, their handling, safety, presence of residual shunt and impact on recurrent thromboembolic events (TEs) are rarely compared...
ABSTRACT: Background. Transcatheter patent foramen ovale (PFO) closure can be performed with various devices. However, their handling, safety, presence of residual shunt and impact on recurrent thromboembolic events (TEs) are rarely compared...
ABSTRACT: Background....
09/15/2008
Journal of Invasive Cardiology